Page 1 of Clinical Trials for Gleevec, 515 Total Matches
- 1RecruitingLast Updated: March 27, 2012Condition(s): Neurofibromatosis; Neurofibromas
- 2TerminatedLast Updated: March 12, 2012Condition(s): Chronic Myeloid Leukemia (CML); Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL); Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
- 3TerminatedLast Updated: April 14, 2010Condition(s): Chronic Lymphocytic Leukemia
- 4CompletedLast Updated: April 28, 2011Condition(s): Healthy
- 5TerminatedLast Updated: March 6, 2012Condition(s): Scleroderma
- 6Active, not recruitingLast Updated: November 23, 2008Condition(s): Glioblastoma; Gliosarcoma
- 7Active, not recruitingLast Updated: March 2, 2012Condition(s): Leukemia, Myeloid, Chronic-Phase
- 8CompletedLast Updated: December 18, 2009Condition(s): Leukemia, Myeloid, Chronic
- 9CompletedLast Updated: August 4, 2011Condition(s): Gastrointestinal Stromal Tumors
- 10Active, not recruitingLast Updated: September 26, 2011Condition(s): Ovarian Cancer
- 11Active, not recruitingLast Updated: December 15, 2011Condition(s): Solid Tumor; Thyroid Cancer
- 12CompletedLast Updated: February 20, 2012Condition(s): Chronic Myelogenous Leukemia
- 13TerminatedLast Updated: March 8, 2012Condition(s): GIST; Metastatic Disease
- 14CompletedLast Updated: May 21, 2009Condition(s): Leukemia
- 15CompletedLast Updated: January 11, 2011Condition(s): Gastrointestinal Stromal Tumors
- 16Active, not recruitingLast Updated: October 18, 2011Condition(s): Breast Cancer
- 17CompletedLast Updated: March 15, 2011Condition(s): Prostatic Neoplasms,; Genital Neoplasms, Male,; Neoplasms,; Urogenital Neoplasms,; Genital Diseases, Male,; Prostatic Diseases,; Antineoplastic Agents,; Imatinib
- 18CompletedLast Updated: March 9, 2011Condition(s): Myelofibrosis; Myeloid Metaplasia; Agnogenic Myeloid Metaplasia; Chronic Myelomonocytic Leukemia
- 19TerminatedLast Updated: July 20, 2011Condition(s): Gastrointestinal Stromal Tumors
- 20RecruitingLast Updated: April 18, 2012Condition(s): Chronic Myelogenous Leukemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Gleevec
